Cargando…

SUN-170 Development of Type 1 Diabetes Mellitus on Immune Checkpoint Inhibitor

Introduction: Immune checkpoint inhibitors (ICPi) are used to augment the immune response and have led to improved outcomes in various malignancies. With this enhanced immunologic response comes a spectrum of side effects, known as immune-related adverse events (iRAEs). These are most commonly derma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tsuei, Jessica, Kwan, Christina, Kirkeby, Kjersti
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Diabetes Mellitus and Glucose Metabolism
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6553242/ http://dx.doi.org/10.1210/js.2019-SUN-170

Ejemplares similares

Immune Checkpoint Inhibitor Associated Type 1 Diabetes
por: Duenas, Jose Andres, et al.
Publicado: (2021)

SAT-667 Partial Beta-Cell Destruction: An Atypical Case of Immune Checkpoint Inhibitor Diabetes Mellitus
por: Quandt, Zoe, et al.
Publicado: (2020)

Checkpoint Inhibitor-Associated Autoimmune Diabetes Mellitus: A Case Report
por: Gnanapragasam, Helen Prathiba, et al.
Publicado: (2021)

SUN-LB024 Elevation in Morning Glucose Level May Be a Signal for the Development of Immune Checkpoint Inhibitor (ICPi) Induced Autoimmune Diabetes Insulin
por: Zhang, Amy, et al.
Publicado: (2019)

MON-LB121 New Onset Insulin Dependent Diabetes Mellitus Secondary to Treatment With Immune Checkpoint Inhibitor
por: Bitat, Syed Rabha
Publicado: (2020)

SAT-673 Acute Onset Type 1 Diabetes Mellitus Caused by the Checkpoint Inhibitor Nivolumab
por: Ansari, Mohammad Jamal Uddin, et al.
Publicado: (2020)

SUN-141 Vitamin D Status and Diabetic Control in Children with Type 1 Diabetes Mellitus
por: Gomez, Patricia, et al.
Publicado: (2019)

A Case of Immune Checkpoint Inhibitor Induced Autoimmune Diabetes
por: Thambuluru, Sirisha Reddy
Publicado: (2021)

SUN-673 Development of Euglycemic Diabetic Ketoacidosis in a Patient with Well-Controlled Type 2 Diabetes Mellitus on a Sodium-Glucose Transporter 2 Inhibitor
por: Narang, Disha K, et al.
Publicado: (2020)

SUN-618 Decision Analysis for Glucagon-Like Peptide Receptor Agonists vs. Sodium-Glucose cotransporter2 Inhibitors in Type 2 Diabetes Mellitus
por: khazaali, Ali Al, et al.
Publicado: (2020)

Immune Checkpoint Inhibitor Mediated Insulin Dependent Diabetes: Observations at a Cancer Center
por: Jeun, Rebecca, et al.
Publicado: (2021)

SUN-172 Diabetic Ketoacidosis Precipitated by Treatment with PD-1 Inhibitor: A Rare Immune Related Adverse Event
por: Qureshi, Mohammed
Publicado: (2019)

SUN-639 Secretagogin Levels Are Unrelated to Gestational Diabetes Mellitus in a Cohort of Pregnant Women
por: Deischinger, Carola, et al.
Publicado: (2020)

SUN-156 Exosomal MicroRNA Profile in Korean Obese Subjects with Prediabetes and Those with Type 2 Diabetes Mellitus
por: Park, Hyeong-Kyu, et al.
Publicado: (2019)

SUN-162 Long-Term Evaluation of Intensive Insulin Therapy in Patients with Type 2 Diabetes Mellitus (Value-It Study)
por: Valdez, Ma. Margarita Noreen, et al.
Publicado: (2019)

SUN-LB036 Diabetic Ketoacidosis: A Rare Side Effect of Nivolumab Induced Insulin Dependent Diabetes Mellitus
por: Abid, Haisam, et al.
Publicado: (2019)

SUN-684 The Dance of Diabetes
por: Thakkar, Aditi, et al.
Publicado: (2020)

SUN-635 Profiling of Activation Patterns of Placental mTOR in Pregnancies Complicated by Gestational Diabetes Mellitus
por: Papadopoulou, Anna, et al.
Publicado: (2020)

SUN-633 Increased Risk of Gestational Diabetes Mellitus in Egyptian Females Undergoing In Vitro Fertilization in Alexandria
por: Amin, Noha Gaber, et al.
Publicado: (2020)

SUN-626 Survival of Patients with Gastroenteropancreatic Neuroendocrine Tumors and Diabetes Mellitus in a Seer-Medicare Cohort
por: Thapi, Sahityasri, et al.
Publicado: (2020)

SUN-679 Early Onset Diabetes Mellitus in a Young Woman with Ring Chromosome 13 Syndrome
por: Buehler, Lauren Anne, et al.
Publicado: (2020)

SUN-187 Dolutegravir Causing Diabetes
por: Kamal, Palwasha, et al.
Publicado: (2019)

SUN-177 House Of Carbs: The Path To Euglycemic Dka In Patients With Diabetes On Sglt2 Inhibitors
por: Islam, Julie, et al.
Publicado: (2019)

SUN-686 Diabetic Retinopathy in Latinos with Type 2 Diabetes: Temperance Is Protective
por: Fukunaga, Alex, et al.
Publicado: (2020)

SUN-LB117 Faster Acting Insulin Aspart in Patients With Gestational Diabetes Mellitus - an Early Experience From India
por: Bhattacharyya, Supratik
Publicado: (2020)

SUN-LB110 The Nutrition Education Using a Health Care Application With Artificial Intelligence in Patients With Diabetes Mellitus
por: Higashitani, Takuya, et al.
Publicado: (2020)

SUN-681 Does Short Term Intensive Insulin Therapy in Newly Diagnosed Type 2 Diabetes Mellitus Delay Eventual Insulin Dependence
por: Patil, Madhuri, et al.
Publicado: (2020)

SUN-664 Effects of Acute Hyperglycemia on Monocytes in Type 2 Diabetes
por: Zhang, Rong Mei, et al.
Publicado: (2020)

SUN-688 Pancreatic Cancer in Longstanding Diabetes
por: Suarez, Janine
Publicado: (2020)

SUN-161 Association between Anthropometric Parameters and Recent Diagnosis of Type 2 Diabetes Mellitus in Adult Patients Attended at a General Hospital in Peru
por: Urday Ipanaqué, Diana, et al.
Publicado: (2019)

SUN-692 Comprehensive and Structured Care Program for Patients with Type 2 Diabetes Mellitus: A Preliminary Report from Raipur, Chhattisgarh State of India
por: Dash, Kalpana, et al.
Publicado: (2020)

SUN-127 Diabetic Ketoacidosis Unmasking Glucose-6-Phosphate Dehydrogenase Deficiency in a 25-Year-Old Male with Diabetes Mellitus Type 2: A Case Report
por: Santiago, Aivind Gabrielle, et al.
Publicado: (2019)

SUN-188 Contributing Factors Precipitation Diabetic Ketoacidosis in Patients Using Sodium-Glucose Cotransporter-2 Inhibitor
por: Attia, Jonven, et al.
Publicado: (2019)

SUN-164 Use of Metformin, Premixed Insulin, and Glucagon-Like Peptide-1 Receptor Agonist as a Therapeutic Approach for Uncontrolled Type 2 Diabetes Mellitus
por: Fazeli, Sasan, et al.
Publicado: (2019)

SUN-632 The Impact of Vitamin D Deficiency on Pregnancy in Type 1 Diabetes
por: Kolpakova, Evgenia, et al.
Publicado: (2020)

SUN-171 Glargine Use in a Neonatal Diabetic
por: Sandhu, Sanjeet, et al.
Publicado: (2019)

SUN-675 Breast Cancer Treatment Causes Diabetes
por: Silparshetty, Santh V S, et al.
Publicado: (2020)

SUN-124 Latent Autoimmune Diabetes of the Adult (LADA): Is It Gestational Diabetes?
por: Cruz Dardiz, Nicolas, et al.
Publicado: (2019)

MON-123 Atypical Diabetes Mellitus or Type 1 Diabetes Mellitus?
por: Havrylyan, Andriy, et al.
Publicado: (2019)

SUN-134 The Frequency of Type 1 Diabetes among Adolescent Patients with Moyamoya Disease
por: Kwon, Ahreum, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4j3p1fno90igj3iaa8l18ij8g3